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tTable DS1 Selected characteristics of included randomised placebo-controlled studies assessing the effects of antidepressant treatment of minor depression on depressive symptomatology
Study Intervention (n)
Age,
years
Definition of minor
depression Exclusion criteria Weeks
Continuous
outcome
Dichotomous
outcome Funding
Barrett 200135 Paroxetine (38)
Placebo (39)
18–59 3 of the 9 DSM–III–R
symptoms for major
depression, 1 of these
had to be depressed
mood or anhedonia).
Individuals were excluded if they were
found to have major depression. The trial
included people with dysthymia (but re-
sults are specifically reported for minor
depression).
11 – HRSD score
of less than 7
John A. Hartford Foundation
of New York and the MacArthur
Foundation
Burrows 200236
(USA)
Paroxetine (12)
Placebo (12)
80–97 DSM–IV Individuals were excluded if they were
found to be actively suicidal, psychotic,
or to have major depression.
8 17-item HRSD Clinical Global
Impression of
1 or 2
SmithKline Beecham
Davidson 198837
(USA)
Isocarboxazid (19)
Placebo (16)
18–65 Research Diagnostic
Criteria
The trial included individuals both with
major and minor depression (but results
are specifically reported for minor
depression).
6 – Clinical Global
Impression of
1 or 2
Hoffmann La Roche
Judd 200438 (USA) Fluoxetine (81)
Placebo (81)
18+ National Institute of
Mental Health Diagnostic
Interview Schedule
Individuals were excluded if they were
found to have major depression.
12 17-item HRSD – NIMH, Roher Fund of the
University of California, Eli Lilly
Paykel 198839 (UK) Amitriptyline (19)
Placebo (18)
18–64 Research Diagnostic
Criteria
The trial included individuals both with
major and minor depression (but results
are specifically reported for minor
depression).
6 17-item HRSD – Medical Research Council
Williams 200042
(USA)
Paroxetine (68)
Placebo (70)
60+ DSM–IV Individuals were excluded if they were
found to have major depression. The trial
included those with dysthymia (but results
are reported for minor depression).
11 – HRSD score
of less than 7
John A. Hartford Foundation
of New York and the MacArthur
Foundation
HRSD, Hamilton Rating Scale for Depression.
